Using monoclonal antibodies instead of conventional immunosuppressant drugs preserves stem cells in mouse brains.
Researchers are developing a monthly monoclonal antibody therapy for the treatment and management of chronic pain. The hope is this new therapy can replace opioids for pain management.
